What Is Retatrutide (LY3437943)? A Complete Research Guide
Everything researchers need to know about the first triple GIP/GLP-1/Glucagon receptor agonist — from molecular structure to clinical significance.
Retatrutide vs Semaglutide vs Tirzepatide: A Researcher's Comparison
Triple vs dual vs mono agonist — how the three leading incretin-based compounds stack up across receptor profiles, efficacy, and mechanism.
TRIUMPH-4 Phase 3 Results: 28.7% Weight Reduction Explained
Breaking down the landmark Phase 3 trial that positioned Retatrutide as the most potent weight-loss peptide in clinical development.
The Glucagon Receptor: Why Triple Agonism Changes Everything
The GCG receptor is what separates Retatrutide from every other incretin therapy. Here's the science behind thermogenesis-driven weight loss.
How to Store and Reconstitute Lyophilized Peptides
A practical guide to proper peptide handling — storage temperatures, reconstitution protocols, shelf life, and common mistakes to avoid.
GIP/GLP-1/GCG: The Future of Metabolic Research in 2026
Where the triple-agonist pipeline stands today, what's coming next, and why the incretin field is moving faster than anyone predicted.